NCCIH Research Framework for Clinical Trials
Strategic framework guiding complementary health research from concept to clinical trials.

Understanding the NCCIH Research Framework for Clinical Trials
The National Center for Complementary and Integrative Health (NCCIH) has established a comprehensive research framework designed to guide investigators through the entire spectrum of clinical trial development for complementary and integrative health interventions. This framework serves as a critical resource for researchers seeking to understand how their scientific interests align with available funding opportunities and developmental pathways.
The NCCIH research framework provides investigators with a clear roadmap for moving research from concept through various stages of development to full-scale clinical trials. By establishing distinct developmental phases and corresponding funding mechanisms, NCCIH enables researchers to strategically plan their investigations and identify appropriate funding sources at each stage of their work.
Core Purpose and Objectives of the Framework
The NCCIH research framework serves several critical functions for the scientific community. First, it provides a conceptual framework for NCCIH’s research on complementary and integrative health interventions, establishing a unified approach to how the Center views research development and implementation. This conceptual foundation helps ensure consistency across funding decisions and research priorities.
Second, the framework clearly delineates the purpose of each stage of research, articulating what specific objectives and outcomes should characterize different developmental phases. This clarity helps investigators understand not only what type of research NCCIH funds, but also what constitutes meaningful progress at each stage of development.
Third, the framework is designed to help investigators align their research interests, questions, and approach with the appropriate stage of development. Rather than applying to funding opportunities that may not match their current research phase, investigators can use the framework to identify the stage most appropriate for their work and then select corresponding funding mechanisms.
Finally, the framework provides guidance on available or appropriate funding mechanisms for each stage of research. This guidance is instrumental in helping researchers navigate NCCIH’s diverse portfolio of Notices of Funding Opportunities (NOFOs) and select the mechanism best suited to their research needs.
Developmental Stages in Clinical Research
NCCIH’s research framework recognizes that complementary and integrative health interventions develop along a progression of stages, each with distinct characteristics, objectives, and funding needs. Understanding these developmental stages is essential for investigators seeking to bring new interventions to clinical practice.
Early-Phase Feasibility Research
Early-phase feasibility research represents the initial step in clinical intervention development. This stage focuses on establishing the preliminary evidence and operational infrastructure necessary to conduct larger clinical trials. Feasibility studies examine whether an intervention can be delivered as designed, whether participants will engage with the intervention, and whether outcome measures are appropriate and responsive to change.
Research at this stage typically involves smaller sample sizes and shorter timeframes compared to later phases. The primary goal is to generate data that informs the design of subsequent, larger trials rather than to definitively establish efficacy or effectiveness. Feasibility studies may examine intervention fidelity, participant recruitment and retention, and preliminary evidence of biological or clinical response.
Intermediate-Phase Trials
Intermediate-phase trials build upon the foundation established in feasibility research. These trials are larger than feasibility studies but smaller than full-scale efficacy trials. They serve to refine the intervention protocol, confirm the appropriateness of outcome measures, and generate preliminary evidence of clinical benefit or mechanism of action.
At this stage, researchers begin to generate more robust preliminary data that can support applications for larger, fully-powered clinical trials. Intermediate-phase research helps identify potential challenges that may emerge in larger trials and allows for protocol refinements before investing significant resources in full-scale studies.
Full-Scale Efficacy and Effectiveness Trials
Full-scale trials represent the mature stage of clinical research, where adequately powered studies can definitively establish whether a complementary or integrative health intervention produces clinically meaningful benefits. Efficacy trials test interventions under controlled conditions, while effectiveness trials evaluate interventions in real-world practice settings.
These trials involve substantially larger sample sizes, longer follow-up periods, and more rigorous methodology than earlier-phase research. Full-scale trials provide the evidence base necessary for clinical practice recommendations and potential integration of complementary and integrative health interventions into standard medical care.
Building Blocks: Bridging Basic Research to Clinical Trials
A critical innovation of the NCCIH research framework is its emphasis on supporting the “building blocks” that bridge the gap from basic research to high-impact clinical trials. Recognizing that not all research can or should immediately proceed to large, expensive efficacy trials, NCCIH has created funding opportunities specifically designed to support intermediate research activities.
These building blocks include:
- Feasibility Testing: Determining whether an intervention can be implemented in clinical settings and whether participants will engage with the intervention
- Outcome Measure Assessment: Identifying and validating appropriate outcome measures for the clinical population and condition of interest
- Intervention Fidelity Testing: Ensuring that the intervention is delivered consistently and as designed
- Mechanism of Action Studies: Understanding how and why an intervention produces its effects
- Go/No-Go Decision Planning: Establishing criteria for determining when preliminary research has generated sufficient evidence to proceed to the next phase
By supporting these intermediate activities, NCCIH substantially increases the probability that subsequent full-scale trials will succeed and generate reliable, clinically meaningful results. This approach represents a more efficient and scientifically sound path to clinical translation than attempting to proceed directly from basic research to expensive, full-scale trials.
Types of Interventions Supported by NCCIH
The NCCIH research framework supports investigation of two primary categories of complementary and integrative health interventions, each with distinct characteristics and funding mechanisms.
Mind and Body Interventions
Mind and body interventions encompass practices that involve the integration of mental and physical processes. These include meditation, yoga, tai chi, mindfulness-based stress reduction, and similar practices. NCCIH supports clinical research examining the efficacy and effectiveness of these interventions across various health conditions.
The framework recognizes that mind and body interventions may operate through distinct biological and psychological mechanisms compared to pharmacological or surgical interventions, potentially requiring different research methodologies and comparison conditions.
Natural Product Studies
Natural products include dietary supplements, herbal preparations, and other substances derived from natural sources that are being investigated for potential health benefits. NCCIH supports rigorous clinical research examining the safety, tolerability, efficacy, and effectiveness of natural products for specific health conditions.
Natural product research often requires particular attention to standardization, quality control, and biological mechanism understanding, factors that are explicitly recognized in NCCIH’s research framework and funding opportunities.
Multicomponent and Multisite Interventions
Beyond single-intervention studies, NCCIH’s research framework also supports investigation of multicomponent interventions that combine multiple complementary and integrative health approaches, as well as multisite clinical trials that can generate evidence from diverse populations and settings.
Multisite trials are particularly important for establishing generalizability of findings and ensuring that research results apply across different healthcare systems, demographic populations, and geographic regions. NCCIH provides specific funding mechanisms to support the coordination, data management, and oversight requirements of large multisite trials.
Dissemination and Implementation Research
The NCCIH research framework extends beyond efficacy and effectiveness trials to include dissemination and implementation research. Once evidence supports the use of a complementary or integrative health intervention, researchers can investigate how to effectively communicate this evidence to healthcare providers and patients, and how to implement these interventions in real-world healthcare settings.
Dissemination and implementation research ensures that evidence-based interventions actually reach healthcare providers and patients and are implemented with fidelity in clinical practice, maximizing the public health impact of NCCIH-funded research.
Selecting the Appropriate Funding Opportunity
The NCCIH research framework includes guidance for investigators on selecting appropriate funding opportunities. When investigators have identified their research interests and questions, they should use the framework to determine which developmental stage their proposed research represents. Each stage has corresponding NOFOs with specific requirements, budget limitations, and expected outcomes.
When the appropriate series of funding opportunities has been identified, investigators should choose the funding opportunity that most closely matches the stage of research their project represents. Each series includes funding opportunities for early-phase trials, intermediate trials, and full-scale efficacy, effectiveness, or pragmatic trials.
Each funding opportunity describes what type of preliminary data is needed for the stage of research it supports. Investigators are strongly encouraged to contact the appropriate NCCIH program director before preparing an application to ensure that their proposed study aligns with NCCIH priorities and the specific goals of the selected funding opportunity.
Research Design Requirements
Regardless of which developmental stage an investigator targets, NCCIH has established specific research design requirements that all clinical trial applications must meet. These requirements reflect NCCIH’s commitment to rigorous, high-quality research that can generate reliable and clinically meaningful evidence.
Investigators applying to any NCCIH clinical trial funding opportunity, including those supporting feasibility work, must propose at least one randomized controlled trial design with at least one intervention arm and one comparator arm. There should be strong rationale for the comparator condition, based on the research question to be addressed in the powered trial or future powered trial.
Appropriate comparator conditions may include time and attention control, usual care, standard of care, sham condition, and active comparators. The selection of comparator condition significantly influences the interpretability and clinical relevance of trial results, making this a critical design decision.
Remote and mHealth Interventions
Recognizing the growing importance of technology-enabled interventions, particularly following the COVID-19 pandemic, the NCCIH research framework welcomes research on remotely delivered and mHealth interventions across all developmental stages. Selection of the appropriate funding opportunity for remotely delivered or mHealth interventions depends on the stage of intervention development and the specific approaches included in the intervention.
Remote delivery and mHealth applications can substantially expand access to complementary and integrative health interventions while maintaining research rigor and quality, making them an increasingly important focus of NCCIH-supported research.
Budget and Cost Considerations
The NCCIH research framework acknowledges that research costs increase as investigations progress through developmental stages. Part 2, Section II of every NOFO describes the direct cost limit of the entire award, as well as per-year or per-phase direct cost limits for multi-year awards.
Budgets in excess of specified limits require NCCIH approval in advance of application submission. For large clinical trials exceeding $500,000 in direct costs in any year, investigators must obtain NCCIH permission to apply before submission. This requirement ensures that proposed budgets are appropriate for the scope of work and that NCCIH can adequately plan for high-cost research initiatives.
Strategic Planning and Phased Awards
For multisite clinical trials and large-scale investigations, NCCIH utilizes phased award structures that include planning phases and implementation phases. Transition between phases is dependent on whether negotiated milestones are met for both the coordinating center and data coordinating center.
This phased approach provides researchers with opportunities to plan and finalize protocols, obtain regulatory approvals, and establish operational infrastructure before committing to the full-scale implementation phase. Such strategic planning substantially increases the likelihood of successful trial execution.
Alignment with NCCIH Strategic Priorities
The NCCIH research framework is explicitly aligned with NCCIH’s strategic plan and scientific priority areas. Investigators are strongly encouraged to review the NCCIH strategic plan and active funding opportunities to ensure that their research interests align with Center priorities.
When NCCIH is one of several NIH institutes or centers participating in a funding opportunity, investigators should pay particular attention to statements about NCCIH’s specific research interests within the funding opportunity announcement.
Frequently Asked Questions About the Research Framework
Q: How do I determine which stage of research my project represents?
A: Review the NCCIH research framework to identify the developmental stage that matches your project’s current phase. Consider factors such as your preliminary data, the maturity of your intervention, and your specific research questions. Contact your NCCIH program director for guidance if you are uncertain.
Q: Can I move between funding opportunities at different developmental stages?
A: Yes. The framework is designed to support progression through multiple stages. Successful early-phase and intermediate research provides preliminary data that can support applications for later-stage funding opportunities.
Q: What if my research addresses multiple developmental stages?
A: Select the funding opportunity that matches your primary research focus. If your application is comprehensive enough to address multiple stages, discuss the appropriate mechanism with your NCCIH program director.
Q: How does the framework apply to remotely delivered interventions?
A: Remote delivery methods are compatible with all developmental stages supported by the framework. Select your funding opportunity based on your intervention’s developmental stage rather than its delivery mechanism.
Q: What preliminary data do I need for my proposed funding opportunity?
A: Each funding opportunity describes required preliminary data. Generally, early-phase research requires basic pilot data; intermediate research requires feasibility data; and full-scale trials require robust preliminary evidence of safety and preliminary efficacy or effectiveness.
References
- NCCIH Clinical Trials Funding Opportunities: Overview — National Center for Complementary and Integrative Health, National Institutes of Health. 2024. https://www.nccih.nih.gov/grants/nccih-clinical-trials-funding-opportunities/overview
- NCCIH Clinical Trials Funding Opportunities: Research Framework — National Center for Complementary and Integrative Health, National Institutes of Health. 2024. https://www.nccih.nih.gov/grants/nccih-clinical-trials-funding-opportunities/research-framework
- NCCIH Clinical Trials Funding Opportunities: Frequently Asked Questions — National Center for Complementary and Integrative Health, National Institutes of Health. 2024. https://www.nccih.nih.gov/grants/nccih-clinical-trials-funding-opportunities/faqs
- Mind and Body Clinical Trials Funding Opportunities — National Center for Complementary and Integrative Health, National Institutes of Health. 2024. https://www.nccih.nih.gov/grants/nccih-clinical-trials-funding-opportunities/mind-and-body-clinical-trials-funding-opportunities
- Natural Products Clinical Trials Funding Opportunities — National Center for Complementary and Integrative Health, National Institutes of Health. 2024. https://www.nccih.nih.gov/grants/nccih-clinical-trials-funding-opportunities/natural-products-clinical-trials-funding-opportunities
- Utilizing the NCCIH Framework To Select a Funding Opportunity for Clinical Research — Wendy J. Weber, N.D., Ph.D., M.P.H., National Center for Complementary and Integrative Health. May 18, 2024. https://www.nccih.nih.gov/videos/utilizing-the-nccih-framework-to-select-a-funding-opportunity-for-clinical-research
Read full bio of Sneha Tete














